- Exchange: -
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Axiogenesis AG
AI8:GR
Ticker Delisted
Snapshot for Axiogenesis AG (AI8)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - |
Key Statistics for AI8
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.15 |
| 30 Day Average Volume | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AI8
No data available
Company Profile & Key Executives for AI8
Axiogenesis AG is a biotechnology company. The Company develops novel assays that use differentiated embryonic stem cell that display normal physiological behavior. Axiogenesis products are used in pharmacology and safety screening in the pharmaceutical, chemical, and cosmetics industries.
| Heribert BohlenCEO/Member:Executive Board | Bernd FronholffCFO/COO/Member:Executive Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AI8 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page